79
Participants
Start Date
September 29, 2015
Primary Completion Date
June 21, 2017
Study Completion Date
June 21, 2017
Tralokinumab
Subcutaneous Injection
Placebo
Subcutaneous Injection
Research Site, København NV
Research Site, Hvidovre
Research Site, Odense C
Research Site, Århus C
Research Site, Aalborg
Research Site, Vancouver
Research Site, Montreal
Research Site, Québec
Research Site, Belfast
Research Site, Glasgow
Research Site, Leicester
Research Site, London
Research Site, Manchester
Research Site, Nottingham
Research Site, Southampton
Lead Sponsor
AstraZeneca
INDUSTRY